Phase I trial of Exisulind (Aptosyn™) and CPT-11 in patients with colorectal cancer and other solid tumors.

被引：0
|
作者：
Marshall, JL [1 ]
Park, S [1 ]
Al-Sayed, A [1 ]
Fox, E [1 ]
Rizvi, N [1 ]
机构：
[1] Vincent T Lombardi Canc Res Ctr, Washington, DC USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页码：3713S / 3713S
页数：1
相关论文
共 50 条
  • [31] A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
    Schoemaker, NE
    Kuppens, IELM
    Moiseyenko, V
    Glimelius, B
    Kjaer, M
    Starkhammer, H
    Richel, DJ
    Smaaland, R
    Bertelsen, K
    Poulsen, JP
    Voznyi, E
    Norum, J
    Fennelly, D
    Tveit, KM
    Garin, A
    Gruia, G
    Mourier, A
    Sibaud, D
    Lefebvre, P
    Beijnen, JH
    Schellens, JHM
    Huinink, WWT
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1434 - 1441
  • [32] Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer
    Fujishima H.
    Kikuchi I.
    Miyanaga O.
    Ueda A.
    Baba E.
    Mitsugi K.
    Harada M.
    Nakano S.
    International Journal of Clinical Oncology, 2004, 9 (2) : 92 - 97
  • [33] SIMULTANEOUS ADMINISTRATION OF CPT-11 AND FLUOROURACIL - ALTERATION OF THE PHARMACOKINETICS OF CPT-11 AND SN-38 IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
    SASAKI, Y
    OHTSU, A
    SHIMADA, Y
    ONO, K
    SAIJO, N
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (14) : 1096 - 1098
  • [34] A Phase I dose escalation study of selenomethionine (SLM) in combination with fixed dose irinotecan (CPT-11) in patients with advanced solid tumors
    Fakih, Marwan G.
    Pendyala, Lakshmi
    Creaven, Patrick J.
    Smith, Patrick
    Ross, Mary Ellen
    Rustum, Youcef
    CANCER RESEARCH, 2006, 66 (08)
  • [35] A combination phase I study of amrubicin and irinotecan (CPT-11) in patients with lung cancer.
    Kurata, T
    Kaneda, H
    Tamura, K
    Satoh, T
    Nogami, T
    Uejima, H
    Nakagawa, K
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 703S - 703S
  • [36] Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer
    Nakafusa, Yuji
    Tanaka, Masayuki
    Ohtsuka, Takao
    Miyoshi, Atsushi
    Kohya, Naohiko
    Kitajima, Yoshihiko
    Sato, Seiji
    Mochinaga, Sakiko
    Dohi, Sawako
    Miyazaki, Kohji
    MOLECULAR MEDICINE REPORTS, 2008, 1 (06) : 925 - 930
  • [37] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [38] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [39] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [40] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237
12345